|Articles|October 1, 2002
- Applied Clinical Trials-10-01-2002
Bert Spilker
Bert Spilker has been involved in clinical trials for 30 years. He?s written books, founded companies, and helped steer regulatory agencies. Now he wants to change how drugs are developed.
Advertisement
Articles in this issue
about 23 years ago
IRBs in the Spotlightabout 23 years ago
Building a Home Networkabout 23 years ago
A Dream Unfulfilled: European Clinical Trials Rules Are Not Workingabout 23 years ago
Learn Before You Leapabout 23 years ago
A Faithful Subjectabout 23 years ago
Using IVRS in Clinical Trial Managementabout 23 years ago
The Virtual Training Processabout 23 years ago
Adding Centers to Boost Subject AccrualNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
2
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
3
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
4
Addressing Preclinical Gaps to Prevent Biotech Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
